Minoryx: Minoryx doses first patient with leriglitazone in Rett syndrome study
Phase 2a TREE study assesses safety and efficacy of leriglitazone
Read full article »
Minoryx is a Spain-based biotechnology company that develops and commercializes novel therapeutics for the treatment of orphan central nervous system disorders.
Read more